NCT04590937View on ClinicalTrials.gov

A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

January 11, 2021

Study Completion Date

January 11, 2021

Conditions
Healthy
Interventions
DRUG

BI 730357

Film-coated tablet

DRUG

CRESTOR®

Film-coated tablet

DRUG

Lenoxin®

Tablet

DRUG

MetfoLiquid GeriaSan®

Oral solution

DRUG

Lasix®

Oral solution

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04590937 - A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body | Biotech Hunter | Biotech Hunter